Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

4Total
Not Applicable (2)
P 2 (1)
P 4 (1)

Trial Status

Unknown2
Not Yet Recruiting2

Clinical Trials (4)

Showing 4 of 4 trials
NCT06944288Not ApplicableNot Yet Recruiting

Microbiota as Early Diagnostic and predictivE Factor for Osteoarthritic Degeneration and Microbial Contamination

NCT06605651Phase 2Not Yet Recruiting

Proof of Concept Study to Assess Safety and Efficacy of Phage Therapy in Hip or Knee Prosthetic Joint Infections Due to Staphylococcus Aureus Treated by DAIR.

NCT04488458Not ApplicableUnknown

Susceptibility Testing of Biofilm to Guide Treatment of Periprosthetic Joint Infections

NCT03389646Phase 4Unknown

CERAMENTTM|G and V in the Management of Hip and Knee Arthroplasty Revisions (Revision Arthroplasty Italy)

Showing all 4 trials

Research Network

Activity Timeline